First product chambers placed in GEA's "Factory of the Future"

Published: 24-Jul-2025

Responding to the growing demand for freeze-drying systems, GEA Pharma & Healthcare is investing €80m in the construction of a pharmaceutical technology centre in Elsdorf (North Rhine-Westphalia)

The relocation of the previous operations in Hürth to Elsdorf has now begun. Partial approval was granted by the authorities in July 2025. 

Shortly after the partial handover, the first product chambers — central components for the production of freeze dryers in which the actual drying process takes place — were delivered.

Covering an area of more than 40,000 square metres, the new competence and production center will primarily be used for the construction of freeze-drying systems

Covering an area of more than 40,000 square metres, the new competence and production center will primarily be used for the construction of freeze-drying systems

The installation of the first freeze-dryers at the new location represents an important milestone in the construction of GEA's new pharmaceutical technology centre.

Covering an area of more than 40,000 square metres, the new competence and production centre will primarily be used for the construction of freeze drying systems, which are used worldwide for the manufacture of injectable drugs such as vaccines.

The complete relocation of the production, storage and laboratory areas, as well as the administrative functions, will take place in the fourth quarter of 2025.

Strategic investment in innovation and sustainability

The “Factory of the Future” in Elsdorf stands for future-proof production processes, consistent digitalisation and sustainable construction.

The photovoltaic system generates environmentally friendly electricity, waste heat is recycled, and green roof areas foster a pleasant working environment and promote biodiversity.

An intelligent warehouse management system and digital workflows ensure increased efficiency and transparency in operations.

Further assembly in “early access” mode

The partial approval gives the GEA team access to the first assembly areas while construction work continues elsewhere.

This means that the assembly of complex systems can begin at an early stage, avoiding time-consuming relocation of these large components at a later date.

The gradual commissioning process guarantees that the project will be completed on time and within budget. 

In brief: facts about the new pharmaceutical technology centre

  • New building enables growth and innovation in the strategically important pharmaceutical sector
  • GEA's second factory of the future is being built in Elsdorf on a site covering more than 40,000 m²
  • The construction of the new site in Elsdorf complies with the highest sustainability standards (own energy generation, CO₂ neutrality) and includes new, innovative digital solutions for the entire value chain
  • All 250 permanent employees will move to the new location
     

Trending Articles

You may also like